(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LEVITASBIO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

LEVITASBIO

ST13

US500000090439965

Class

1, 5, 9, 10, 42

Filing

90439965

Registration

7323148

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

56

Latest update

03/05/2024

Trademark type

Combined

Nice classes

1, 5, 9, 10, 42

Filing date

12/31/2020

Registration date

03/05/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/05/2024

Last transaction

03/05/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

01/18/2022

First use in commerce

01/18/2022

Drawing code

3

Owner type

03

Owner location

MENLO PARK, CA, US

Examiner

CASE, LEIGH CAROLINE

Law office

M30

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized mark "LEVITASBIO" where stylized rectangular shapes make up the letter "E" and stylized circular shapes make up the letter "A".

Holders and representatives

Holders

LEVITASBIO, INC.
Levitas, Inc.

Representatives

Jason Sanders Sanders IP Law

Technical classification

Nice Classes

Class 1Class 5Class 9Class 10Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Reagentscartridges and testing kits comprised of diagnostic reagents and assays for testing cell gene expression and cell data for scientific and research purposes; testing kitschemical preparationscompoundsenzymesfluids sold together as a unit for scientific and research purposes

Class 5

Reagentscartridges and testing kits comprised of medical diagnostic reagents and assays for testing cell gene expression and cell data for medical diagnostic use; Testing kitschemical preparationscompoundsenzymesfluids sold together as a unit for medical diagnostic purposes

Class 9

Scientific equipmentdevices for analyzing nucleic acidsfor RNA and DNA analysisfor DNA sequencing for the purpose of performing scientific researchdownloadable software for use therewith sold as a unit; medical diagnostic apparatus for high-speed analysis for assessing cells for the purpose of performing scientific research

Class 10

Medical equipmentdevices for analyzing nucleic acidsfor RNA and DNA analysisfor DNA sequencing for the purpose of providing medical treatment and diagnosisdownloadable software for use therewith sold as a unit; medical diagnostic apparatus for high-speed analysis for assessing cells for the purpose of providing medical treatment and diagnosis

Class 42

Scientific and laboratory researchdevelopmentconsultingdesignengineering and testing services in the fields of biotechnologypharmaceuticalscomputer sciencechemistrybiochemistrybiologygeneticsgenotyping and forensic sciences; Scientific research featuring the analysisdetection and isolation of biological substances in samples in the fields of geneticsgenotypingDNA analysis and pharmacogenetics

Publications

History of USPTO decisions and trademark events.

56 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/05/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

03/05/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/27/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/26/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/06/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/05/2024

EX2G

SOU EXTENSION 2 GRANTED

01/05/2024

IUAF

USE AMENDMENT FILED

01/03/2024

NREV

NOTICE OF REVIVAL - E-MAILED

01/03/2024

EISU

TEAS STATEMENT OF USE RECEIVED

01/03/2024

TPEX

SOU EXTENSION RECEIVED WITH TEAS PETITION

01/03/2024

PETG

PETITION TO REVIVE-GRANTED

01/03/2024

PROA

TEAS PETITION TO REVIVE RECEIVED

01/03/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/28/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/28/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/28/2023

EXT2

SOU EXTENSION 2 FILED

12/20/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/20/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/20/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/20/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/20/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/20/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/01/2023

EX1G

SOU EXTENSION 1 GRANTED

06/30/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/20/2023

EXT1

SOU EXTENSION 1 FILED

06/13/2023

EEXT

SOU TEAS EXTENSION RECEIVED

06/13/2023

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

06/13/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/20/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/25/2022

PUBO

PUBLISHED FOR OPPOSITION

10/25/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/05/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/19/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/29/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/29/2022

ALIE

ASSIGNED TO LIE

08/29/2022

NREV

NOTICE OF REVIVAL - E-MAILED

08/19/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/19/2022

PETG

PETITION TO REVIVE-GRANTED

08/19/2022

PROA

TEAS PETITION TO REVIVE RECEIVED

08/19/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/18/2022

GNRT

NON-FINAL ACTION E-MAILED

02/18/2022

CNRT

NON-FINAL ACTION WRITTEN

02/18/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/26/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/26/2022

ALIE

ASSIGNED TO LIE

01/26/2022

ALIE

ASSIGNED TO LIE

01/17/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/13/2022

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

10/20/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/13/2021

GNRT

NON-FINAL ACTION E-MAILED

07/13/2021

CNRT

NON-FINAL ACTION WRITTEN

07/13/2021

DOCK

ASSIGNED TO EXAMINER

07/07/2021

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

03/30/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/29/2021

NWAP

NEW APPLICATION ENTERED

01/04/2021

Continuous trademark protection

Get notified about every new filing that threatens LEVITASBIO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.